Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

1.72
+0.04002.38%
Post-market: 1.770.0500+2.91%19:59 EDT
Volume:114.57M
Turnover:264.58M
Market Cap:97.46M
PE:-1.36
High:2.78
Open:2.36
Low:1.71
Close:1.68
Loading ...

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires Live
·
9 hours ago

Top Midday Gainers

MT Newswires
·
11 hours ago

Black Diamond Therapeutics Shares up 36% on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie's

Reuters
·
Yesterday

Black Diamond Therapeutics Shares up 32.7% Premarket on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
Yesterday

BUZZ-Black Diamond rises on licensing deal for tumor treatment

Reuters
·
Yesterday

Black Diamond, Servier announce global licensing agreement for BDTX-4933

TIPRANKS
·
Yesterday

BRIEF-Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy

Reuters
·
Yesterday

Black Diamond Therapeutics - to Receive $70 Million Upfront, up to $710 Million in Milestones

THOMSON REUTERS
·
Yesterday

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

GlobeNewswire
·
Yesterday

Black Diamond Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
10 Mar

Black Diamond Therapeutics Reports 2024 Financial Results

TIPRANKS
·
08 Mar

Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel

TIPRANKS
·
07 Mar

Black Diamond Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
07 Mar

Black Diamond Therapeutics Inc : Wedbush Cuts Target Price to $11 From $16

THOMSON REUTERS
·
07 Mar

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

MT Newswires Live
·
07 Mar